ACG GUIDELINE AND CURRENT PRACTICE IN GASTRO ESOPHAGEAL REFLUX DISORDER- AN OUTCOME BASED STUDY

Author(s)

Mathew JS1, Manne RV N1, Saraswathy GR2, K Viswam S3
1MS Ramaiah University of Applied Sciences, Bangalore, India, 2M S Ramaiah University of Applied Sciences, Bangalore, India, 3M.S. Ramaiah University of Applied Sciences, Bangalore, India

OBJECTIVES: Proton pump inhibitors (PPIs) are the evidence-based therapy for Gastro esophageal Reflux Disorder (GERD). The efficiency of PPIs has driven to its over-utilization and the protracted recipients are targets to its long-term adverse effects. Despite the accessibility of globally acknowledged guidelines, there remains a significant variation between guidelines and the fundamental practice in the treatment of GERD all over the globe, which pose a burden in the quality of patient care. The present study aims to investigate the usefulness of current Hospital Based Practice (HBP) and its adherence to American College of Gastroenterology (ACG) guideline in the management of GERD.

METHODS: This prospective, observational study was conducted among 139 patients who presented with typical and atypical symptoms of GERD to the Outpatient Department of Gastroenterology. The enrolled patients were categorized as ACG group and HBP group based on the therapeutic recommendations made by the gastroenterologists and each group was analyzed majorly in 4 areas (choice of drug, frequency prescribed, duration of therapy and maintenance therapy) for the variances in outcome.The study groups were assessed for their improvement in symptoms using the Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL-15 ) questionnaire and adherence to the prescribed therapy was evaluated using Morisky Medication Adherence Scale (MMAS-4).

RESULTS: The study subjects had an average severity score of 66±8.5, 64±10.2 in ACG and HBP group respectively. Adherence to the ACG guidelines in relation to the drug of choice was 90.6%,83.5% in frequency prescribed and 24.46% in duration of therapy, where in HBP it was 9.4%,69.6% and 75.5% respectively. Only 7.19% (n=10) of study population received maintenance therapy.

CONCLUSIONS: Study showed significant symptoms relief in both the therapy groups (ACG and HBP), although the symptom relief was more significant among the ACG group,hence adopting the more significant changes can benefit the HBP enormously.

Conference/Value in Health Info

2018-09, ISPOR Asia Pacific 2018, Tokyo, Japan

Value in Health, Vol. 21, S2 (September 2018)

Code

PGI9

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Health Care Research, Prescribing Behavior, Quality of Care Measurement, Treatment Patterns and Guidelines

Disease

Gastrointestinal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×